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atheroma throughout a segment of coronary artery of at least 30
mm in length (1). This was performed in a large cohort of subjects
and includes sites that do not contain significant obstructive
disease. Although one segment was studied in each subject, each
epicardial coronary artery is reflected in the total cohort (i.e., this
is not a study of disease limited to the left main segment). Further,
the volumetric approach defines segments by the fixed anatomic
presence of arterial side branches and provides a greater opportu-
nity for precise matching and investigation of the factors that
influence the natural history of atherosclerosis.
Studying atherosclerosis within the left main coronary artery,
the investigators found no significant correlation between the level
of low density lipoprotein (LDL) cholesterol and atheroma burden
(8), in support of our findings. Interestingly, they found a signif-
icant correlation between baseline LDL cholesterol and progres-
sion of atheroma at the region studied. The degree of correlation
was much greater than what has been subsequently been reported
for the relationship between the degree of change in LDL
cholesterol and atheroma volume in patients treated with a statin
(6). Given that atherosclerosis is a complex pathological process
that results from the influence of a large number of factors on the
arterial wall and that there is a substantial overlap between levels of
LDL cholesterol and incidence of cardiovascular disease, it would
be surprising to expect anything greater than a mild correlation
between these factors at most.
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Most Asymptomatic Diabetic Patients Will
Not Benefit From Coronary Revascularization
In a study recently published in JACC, Scognamiglio et al. (1)
suggest that patients with type 2 diabetes mellitus with 1 other
risk factor should undergo routine stress imaging to diagnose
asymptomatic coronary artery disease (CAD), a strategy the
investigators believe will lead to early aggressive medical treatment
and more favorable coronary anatomy that is more suitable for
revascularization.
As cited by Scognamiglio et al. (1), the risk of major coronary
events in diabetic patients is similar to that of nondiabetic patients
with established coronary disease. Risk factors in these patients should
be treated as aggressively as in CAD patients even without evidence of
CAD on diagnostic imaging. Therefore, routine assessment of
asymptomatic diabetic patients by stress imaging to clarify the need
for more aggressive risk-factor modification is not warranted.
Both coronary revascularization by surgery (coronary artery
bypass graft [CABG]) and percutaneous coronary intervention
(PCI) differ in their influence on prognosis. Although no random-
ized study to date has shown PCI to improve elective patient
prognosis, CABG improves survival of elective patients in 4
categories: patients with left main coronary disease; patients with
3-vessel disease and decreased left ventricular function; patients
with multivessel disease involving the proximal left anterior de-
scending artery; and patients with diabetes mellitus and multivessel
disease (2). Most other patients undergo revascularization for
control of symptoms. For asymptomatic patients to benefit prog-
nostically from revascularization, one of the 4 previously men-
tioned indications must apply (and the procedure should be
CABG), otherwise no mortality benefit should be anticipated.
Revascularization, therefore, should be limited to patients who are
symptomatic or fall under 1 of the 4 previously mentioned
categories. Noninvasive testing should be performed in asymptom-
atic diabetics only if clinical assessment suggests that they belong
to a high-risk group. Only those patients with impaired cardiac
function or high-risk stress imaging should undergo coronary
angiography.
Early detection and aggressive modification of non–insulin-
dependent diabetes mellitus and other risk factors in adherence to
published guidelines (3,4) will help prevent CAD and its compli-
cations, whereas routine stress imaging and revascularization for
the most part will not.
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REPLY
In their letter, Drs. Rott and Leibowitz correctly reported the
current indications to myocardial revascularization in type 2
diabetic (DM2) patients, and they concluded that an aggressive
diagnostic approach (like that used in our study) (1) may not be
useful. Unfortunately, they do not take into account that previous
results with percutaneous coronary intervention or aorto-coronary
artery bypass have been obtained applying an old, bankrupt
diagnostic approach to ischemic heart disease (IHD) in DM2
patients. In fact, in the past 20 years, cardiovascular mortality
(mainly due to IHD) increased by 40% to 50% in diabetic patients,
whereas in the same period of observation, major cardiovascular
disease mortality in the nondiabetic population was reduced by
about 30% (2). The poor results of myocardial revascularization
procedures in DM2 patients are largely caused by the extension of
atherosclerotic involvement of coronary artery disease (CAD) at
the moment of diagnosis. The current American Diabetes Asso-
ciation guidelines (3,4) do not allow for the identification of a
population of diabetic patients with a high prevalence of CAD but
only those DM2 patients with advanced atherosclerosis involving
multiple coronary vessels. Similar results may be obtained by
applying the suggestion reported by Drs. Rott and Leibowitz in
their letter: “Noninvasive testing should be performed in asymp-
tomatic diabetics only if clinical assessment suggests that they
belong to a high-risk group.” But all diabetic patients belong to a
high-risk group for cardiovascular mortality!
In an autopsy study, Goraya et al. (5) showed that, among
diabetic decedents without clinical CAD, almost three-fourths had
high-grade atherosclerosis and more than one-half had multivessel
coronary disease. Moreover, Haffner et al. (6) showed that diabetic
patients who have not had a previous myocardial infarction (MI)
have outcomes similar to those of patients without diabetes who
have had a prior MI. In light of these statements we applied to
DM2 patients a diagnostic approach similar to one that is currently
applied in nondiabetic patients with clinical manifestation of
CAD. The diagnostic approach we proposed in our study (1)
allowed us to identify an early phase of CAD in asymptomatic
diabetic patients, and the favorable anatomy of coronary vessels
(with the high prevalence of one-vessel disease) has the potential to
improve results of revascularization procedures and the rate of
cardiac events in asymptomatic diabetic patients.
Finally, in our opinion, we must not be resigned to accept the
current bankrupt diagnostic and therapeutic approach to ischemic
heart disease in diabetic patients, and research into a “New Deal”
is mandatory.
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